Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* End-stage renal disease~* Undergoing continuous ambulatory peritoneal dialysis as a renal replacement therapy~* Clinical diagnosis of a peritonitis episode in a continuous ambulatory peritoneal dialysis patient~* Developing the first continuous ambulatory peritoneal dialysis related peritonitis episode~Exclusion Criteria:~* Being treated with aminoglycoside antibiotics and vancomycine within the previous 3 months~* Detection of mechanical occlusion of external ear~* Having signs of disturbed integrity of tympanic membrane on otoscopy or tympanometry~* History of a continuous ambulatory peritoneal dialysis related peritonitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- N-acetylcysteine (Type: EXPERIMENTAL): N-acetylcysteine 600 mg twice daily + vancomycine and/or amikacin
- Controls (Type: NO_INTERVENTION): Vancomycine and/or amikacin alone

Based on this trial design, predict the completion outcome and termination type (if applicable).